Financial Snapshot

Revenue
$543.3M
TTM
Gross Margin
-115.24%
TTM
Net Earnings
$108.3M
TTM
Current Assets
$584.7M
Q3 2024
Current Liabilities
$94.35M
Q3 2024
Current Ratio
619.72%
Q3 2024
Total Assets
$854.2M
Q3 2024
Total Liabilities
$129.5M
Q3 2024
Book Value
$724.7M
Q3 2024
Cash
$550.9M
Q3 2024
P/E
5.986
Nov 29, 2024 EST
Free Cash Flow
$94.53M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018
Revenue $53.76M $67.42M $103.0M $48.87M $17.42M $12.87M
YoY Change -20.26% -34.54% 110.74% 180.54% 35.35%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018
Revenue $53.76M $67.42M $103.0M $48.87M $17.42M $12.87M
Cost Of Revenue $116.3M $159.0M $238.2M $14.17M $27.98M $17.74M
Gross Profit -$62.52M -$91.63M -$135.2M $34.70M -$10.57M -$4.870M
Gross Profit Margin -116.3% -135.9% -131.28% 71.0% -60.68% -37.84%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018
Selling, General & Admin $81.79M $95.26M $93.16M $48.17M $48.37M $24.64M
YoY Change -14.15% 2.25% 93.41% -0.41% 96.31%
% of Gross Profit 138.82%
Research & Development $107.2M $62.55M $811.6M $111.2M $42.77M $40.58M
YoY Change 71.36% -92.29% 629.7% 160.07% 5.4%
% of Gross Profit 320.55%
Depreciation & Amortization $23.39M $23.74M $15.67M $10.70M $7.200M $3.800M
YoY Change -1.5% 51.47% 46.49% 48.61% 89.47%
% of Gross Profit 30.84%
Operating Expenses $207.2M $62.55M $343.5M $144.5M $88.93M $67.96M
YoY Change 231.2% -81.79% 137.65% 62.51% 30.86%
Operating Profit -$269.7M -$154.2M -$478.7M -$109.8M -$99.50M -$72.83M
YoY Change 74.92% -67.79% 335.86% 10.37% 36.62%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018
Interest Expense $14.24M $302.0K -$235.0K -$20.03M -$630.0K $1.690M
YoY Change 4614.57% -228.51% -98.83% 3079.37% -137.28%
% of Operating Profit
Other Income/Expense, Net
YoY Change

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018
Pretax Income -$260.0M -$249.2M -$412.5M -$129.9M -$100.1M -$71.13M
YoY Change 4.34% -39.6% 217.67% 29.68% 40.77%
Income Tax $198.0K -$126.0K -$782.0K -$730.0K -$250.0K $110.0K
% Of Pretax Income
Net Earnings -$260.2M -$249.0M -$411.7M -$129.1M -$99.87M -$71.24M
YoY Change 4.47% -39.51% 218.86% 29.29% 40.19%
Net Earnings / Revenue -483.96% -369.37% -399.76% -264.21% -573.31% -553.54%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.18 -$1.28 -$2.200M -$725.5K -$566.0K -$403.7K

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018
Cash & Short-Term Investments $404.4M $497.7M $816.1M $1.325B $32.10M $60.60M
YoY Change -18.75% -39.01% -38.42% 4028.35% -47.03%
Cash & Equivalents $402.5M $495.8M $811.5M $1.323B $30.70M $21.40M
Short-Term Investments $1.936M $1.936M $4.648M $2.600M $1.500M $39.30M
Other Short-Term Assets $26.18M $50.75M $49.24M $48.30M $1.200M $800.0K
YoY Change -48.41% 3.07% 1.95% 3925.0% 50.0%
Inventory $24.80M $23.99M $56.16M $14.50M $6.200M $3.000M
Prepaid Expenses
Receivables $17.08M $9.002M $18.50M $1.800M $17.20M $6.900M
Other Receivables $5.926M $2.551M $0.00 $0.00 $500.0K $1.700M
Total Short-Term Assets $478.4M $584.0M $940.0M $1.390B $57.20M $73.10M
YoY Change -18.09% -37.87% -32.37% 2329.9% -21.75%
Property, Plant & Equipment $278.6M $241.7M $200.4M $100.6M $61.70M $40.50M
YoY Change 15.28% 20.61% 99.2% 63.05% 52.35%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.896M $2.661M $3.512M $5.700M $5.100M $5.200M
YoY Change 8.83% -24.23% -38.39% 11.76% -1.92%
Total Long-Term Assets $309.9M $276.4M $218.2M $121.5M $73.40M $52.60M
YoY Change 12.09% 26.68% 79.61% 65.53% 39.54%
Total Assets $788.2M $860.5M $1.158B $1.511B $130.6M $125.7M
YoY Change
Accounts Payable $48.03M $73.46M $127.7M $21.70M $5.300M $9.000M
YoY Change -34.62% -42.47% 488.49% 309.43% -41.11%
Accrued Expenses $49.48M $39.29M $46.80M $50.00M $12.10M $12.30M
YoY Change 25.93% -16.05% -6.4% 313.22% -1.63%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $5.005M $4.980M $3.469M $3.200M $2.000M $100.0K
YoY Change 0.5% 43.56% 8.41% 60.0% 1900.0%
Total Short-Term Liabilities $186.4M $156.2M $357.7M $247.6M $28.10M $28.10M
YoY Change 19.31% -56.33% 44.48% 781.14% 0.0%
Long-Term Debt $36.82M $37.11M $25.42M $52.00M $77.10M $0.00
YoY Change -0.77% 45.95% -51.11% -32.56%
Other Long-Term Liabilities $48.10M $133.9M $86.61M $500.3M $66.60M $65.40M
YoY Change -64.07% 54.59% -82.69% 651.2% 1.83%
Total Long-Term Liabilities $84.92M $171.0M $112.0M $552.3M $143.7M $65.40M
YoY Change -50.34% 52.63% -79.72% 284.34% 119.72%
Total Liabilities $271.3M $327.2M $469.8M $800.0M $173.4M $93.60M
YoY Change -17.09% -30.34% -41.28% 361.36% 85.26%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018
Basic Shares Outstanding
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $648.24 Million

About CureVac N.V.

CureVac BV is a clinical-stage biopharmaceutical company, which engages in developing transformative medicines based on messenger ribonucleic acid (mRNA). The company is headquartered in Tuebingen, Baden-Wuerttemberg and currently employs 999 full-time employees. The company went IPO on 2020-08-14. Fueled by proprietary RNA technology platform combined with two decades of science and manufacturing, The Company is dedicated to creating novel treatments that enable the body to make its own prophylactic and therapeutic drugs.

Industry: Pharmaceutical Preparations Peers: Affimed N.V. BioNTech SE Immatics N.V. MAINZ BIOMED N.V.